Clostridium perfringens (Cl. welchii) in the human gastro-intestinal tract.
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001647:Bile Acids and Salts; D002353:Carrier State / Q000382:microbiology; D002452:Cell Count; D002648:Child; D002675:Child, Preschool; D003015:Clostridium Infections; D003016:Clostridium perfringens / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D004064:Digestive System / Q000382:microbiology*; D004285:Dogs; D004352:Drug Resistance, Microbial; D004751:Enteritis; D004768:Enterotoxins / Q000096:biosynthesis; D005243:Feces / Q000382:microbiology; D005516:Food Microbiology; D005517:Foodborne Diseases; D005769:Gastrointestinal Motility; D006801:Humans; D007223:Infant; D007419:Intestinal Secretions; D007420:Intestine, Large / Q000382:microbiology; D007421:Intestine, Small / Q000382:microbiology; D009336:Necrosis; D012874:Skin Diseases, Infectious; D013171:Spores, Bacterial / Q000254:growth & development
D000900:Anti-Bacterial Agents; D001647:Bile Acids and Salts; D004768:Enterotoxins